Temovate
Temovate
- In our pharmacy, you can buy temovate without a prescription, with delivery in 5–14 days throughout the United Kingdom. Discreet and anonymous packaging.
- Temovate (clobetasol propionate) is used to treat inflammatory skin conditions such as psoriasis, eczema and lichen planus; it is a very potent topical corticosteroid that reduces inflammation, itching and immune activity by activating glucocorticoid receptors.
- The usual dose is to apply a thin film to the affected area once or twice daily; treatment is typically limited to short courses (commonly up to 2 weeks) and should be used sparingly and only as directed.
- The form of administration is topical – cream, ointment or scalp solution applied directly to the skin.
- The effect often begins within hours for vasoconstriction and commonly shows noticeable reduction in redness and itching within 24–48 hours.
- The duration of action is generally 12–24 hours, which is why once or twice daily application is usual; overall treatment duration should be short to minimise risks.
- Avoid alcohol while using temovate; although there is no specific direct interaction, excessive alcohol can impair skin healing and increase risk if systemic absorption occurs with extensive or prolonged use.
- The most common side effects are local skin reactions such as burning, irritation and skin thinning (atrophy); prolonged use can also cause stretch marks, telangiectasia or, rarely, systemic corticosteroid effects.
- Would you like to try temovate without a prescription?
Basic Temovate Information
- INN (International Nonproprietary Name): Paracetamol (example; known as acetaminophen in US/Canada)
- Brand Names Available In United Kingdom: Panadol® (UK) — packaging examples not specified for Temovate
- ATC Code: N02BE01
- Forms & Dosages: Tablets 325mg/500mg/1000mg, syrups 120mg/5ml and 160mg/5ml, suppositories 125mg–500mg, effervescent 500mg/1000mg, IV solution 10mg/ml (100ml vial)
- Manufacturers In United Kingdom: GSK (Panadol brands) and generic suppliers (Actavis, Sandoz) — specific Temovate manufacturers not specified
- Registration Status In United Kingdom: Approved by MHRA (UK) — specific registration details for Temovate not specified
- OTC / Rx Classification: Generally OTC for standard oral forms; prescription-only for high-dose or intravenous forms — Temovate classification not specified in this dataset
Latest Research Highlights
Clinicians and regulators in the UK and EU continue to emphasise the balance between strong symptomatic control and safety when using super‑potent topical corticosteroids.
Recent literature (2022–2025) reports that clobetasol propionate 0.05% produces rapid clearing of severe plaques and itch within days in many patients.
Systematic reviews and guideline updates flag the effectiveness for short courses but caution about local skin atrophy, striae and possible HPA axis suppression with prolonged use or large treated areas.
MHRA Yellow Card and EMA pharmacovigilance summaries list predominantly local adverse reactions, with serious systemic sequelae being uncommon when guidelines are followed.
ATC classification for clobetasol is D07AC01 and in the UK it is prescription-only according to regulatory guidance summarised in recent updates.
| Efficacy Endpoints | Common Local Adverse Events | Safety Signals (2022–2025) |
|---|---|---|
| Rapid reduction in erythema, scaling and pruritus (days) | Skin atrophy, telangiectasia, local irritation (reported commonly) | Most reports local; rare HPA axis suppression with prolonged/extensive use |
| PASI or lesion clearance for limited severe plaques | Striae when used long term or under occlusion | Pharmacovigilance highlights importance of limiting duration and surface area |
Clinical Effectiveness In The UK
Dermatology audits across NHS services show clobetasol 0.05% provides prompt symptomatic relief for severe, localised disease.
Typical clinical scenarios include palmoplantar psoriasis, thick recalcitrant plaques and scalp disease where rapid control is needed.
Primary care usually starts with lower‑potency steroids and refers persistent or severe cases to dermatology where clobetasol is reserved for flares.
Adherence to short courses (commonly ≤2–4 weeks) delivers substantial quality‑of‑life improvements for many patients.
- PASI reduction for treated plaques reported in audits.
- Patient‑reported itch score improvements within days.
- Typical NHS treatment durations recorded at 2–4 weeks for super‑potent use.
| Primary Care Use | Secondary Care Use |
|---|---|
| Start with lower potency; small, short courses via GP | Reserve clobetasol for flares, recalcitrant plaques and specialist‑directed regimens |
| GPs refer if no response or widespread disease | Dermatology audits guide treatment duration and follow‑up |
Indications And Expanded Uses
MHRA‑aligned indications for super‑potent clobetasol preparations focus on steroid‑responsive dermatoses requiring high potency control.
Common licensed uses include severe plaque psoriasis, lichen planus and certain chronic eczemas where lesser agents have failed.
Dermatologists may employ short‑term off‑label uses for limited, recalcitrant lesions or to bridge until steroid‑sparing treatments take effect.
- MHRA‑Approved Uses: Severe plaque psoriasis, lichen planus, discoid eczemas and resistant chronic hand eczema.
- Common Off‑Label Uses: Lichenified areas needing controlled short courses; limited use on scalp plaques as specialist choice.
| Anatomical Area | Recommended Approach |
|---|---|
| Scalp | Use scalp solution/shampoo formulations; specialist guidance advised |
| Nails | Limited benefit topically; consider specialist assessment |
| Face And Flexures | Avoid super‑potent agents; prefer milder steroids or specialist advice |
| Body Plaques | Cream or ointment formulations for limited severe plaques |
Composition And Brand Landscape
The active ingredient in super‑potent preparations is clobetasol propionate 0.05% by weight in the vehicle specified.
UK market names include Dermovate and multiple generics in cream and ointment form, plus scalp solutions and shampoos for scalp disease.
Internationally, Temovate is a well‑known brand name used in some markets.
| Formulation Type | Typical Pack Sizes | Intended Site Of Use |
|---|---|---|
| Cream | 15g, 30g | Body plaques and flexural areas where appropriate |
| Ointment | 15g, 30g | Thicker plaques, dry lichenified skin |
| Scalp Solution/Shampoo | 50ml, 100ml | Scalp psoriasis and alopecic plaques |
- Major UK Suppliers: community pharmacies (Boots, LloydsPharmacy, Superdrug) and hospital formularies.
- ATC Code: D07AC01.
- Classification In UK: prescription‑only (see safety considerations and MHRA guidance).
Contraindications And Special Precautions
Absolute contraindications include known hypersensitivity to clobetasol or any excipient.
Avoid super‑potent steroids on widespread untreated skin infections unless appropriate antimicrobial therapy is given concurrently.
High‑risk groups include children, pregnant or breastfeeding patients, those with extensive disease, thin or fragile skin and people on systemic corticosteroids.
Avoid occlusive dressings unless a clinician instructs otherwise due to increased absorption risk.
Topical clobetasol does not impair driving and has no interaction with alcohol at recommended topical doses.
HPA Axis Risk Factors
Factors increasing HPA suppression risk include large treated surface area, prolonged duration, use under occlusion and younger age.
Dosage Guidelines
Typical NHS advice is to apply a thin film of clobetasol 0.05% once or twice daily to affected areas for short courses, commonly up to 2–4 weeks.
Use the lowest effective potency and switch to maintenance or steroid‑sparing agents for chronic disease.
Paediatric dosing is cautious and should be under specialist supervision with fingertip unit guidance for area‑based dosing.
| Site | Regimen |
|---|---|
| Body Plaques | Thin film once–twice daily for up to 2–4 weeks |
| Scalp | Use scalp solution/shampoo as product leaflet directs; specialist advice for frequency |
| Face/Neck | Generally avoid super‑potent agents; use milder steroid if needed |
- Treatment Duration: usually ≤2–4 weeks for continuous use.
- Maximum Treated Area: keep exposure limited; large surface areas increase systemic risk.
- Fingertip Unit Guidance: use fingertip units to estimate dose by body area and minimise excess application.
Interactions Overview
Pharmacokinetic interactions from topical clobetasol are uncommon with short, limited applications.
Clinical interactions arise when systemic corticosteroid exposure increases due to combined topical and systemic therapy or extensive topical absorption.
Concomitant use with systemic immunosuppressants can magnify systemic steroid effects and warrant monitoring.
- Document systemic steroid use when issuing repeat topical steroid prescriptions.
- Avoid live vaccines or seek specialist advice if systemic immunosuppression is suspected.
- Report suspected interaction events via MHRA Yellow Card reporting.
| Interaction Mechanism | Clinical Consequence |
|---|---|
| Additive adrenal suppression (topical + oral steroids) | HPA axis suppression, need for endocrine assessment if symptomatic |
| Increased systemic absorption (large area/occlusion) | Potential systemic corticosteroid effects |
Cultural Perceptions And Patient Habits
Many patients in the UK express "steroid phobia" and worry about skin thinning and systemic effects.
Online forums such as Mumsnet and Patient.info commonly contain mixed advice and safety concerns about long‑term steroid use.
Conversely, some patients over‑apply topical steroids seeking quick relief, which raises safety risks.
- Common Misconceptions: fear of permanent skin damage, belief that stronger is always better, desire for steroid‑free alternatives.
- Typical Patient Behaviour: consult pharmacists first for advice then see GP if symptoms persist.
Community pharmacies such as Boots and LloydsPharmacy are frequent first points of contact and trusted for counselling on Dermovate and clobetasol propionate 0.05% application.
Availability And Pricing Patterns
Clobetasol 0.05% products such as Dermovate and generics are prescription‑only in the UK and supplied via NHS prescriptions or private pharmacies.
Prescription charges apply in England depending on the current NHS per‑item fee, while prescriptions are free in Scotland, Wales and Northern Ireland.
Private prices vary by brand and pack size, and online pharmacies increasingly offer prescription fulfilment with home delivery.
In our online pharmacy, temovate is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
| Access Route | Typical Cost Factors | Major Pharmacy Channels |
|---|---|---|
| NHS Prescription | Depends on prescription charging rules by nation | Community pharmacies, hospital pharmacies |
| Private Prescription | Brand, pack size, dispensing fee and delivery | Boots, LloydsPharmacy, Superdrug, online pharmacies |
Comparable Medicines And Preferences
Treatment choice depends on disease severity and long‑term management needs.
For mild disease start with emollients and low‑potency steroids, escalating only where clinically indicated.
Steroid‑sparing alternatives such as topical calcineurin inhibitors and vitamin D analogues are options for maintenance in appropriate patients.
| Agent | Potency/Type | Typical Indications | Main Risks |
|---|---|---|---|
| Clobetasol (Dermovate) | Super‑potent | Limited severe plaques, scalp disease, recalcitrant lesions | Local atrophy, striae, rare systemic effects with misuse |
| Betamethasone Valerate | Moderate to potent | Mild–moderate eczema and psoriasis | Lower atrophy risk with short courses |
| Topical Tacrolimus/Pimecrolimus | Non‑steroidal | Maintenance in flexural or facial eczema | No atrophy risk; different safety profile |
Frequently Asked Questions
- Is Dermovate/Temovate safe for long‑term use?
No. Super‑potent steroids are intended for short courses because prolonged use increases risk of skin thinning and systemic effects.
- Can I apply it to my face or groin?
Generally avoid these areas with super‑potent agents and seek a milder steroid or specialist advice for such sites.
- What if I miss a dose?
Apply when you remember, but do not double up the next application; follow the prescribed total duration.
- Will it affect my child?
Use in children is cautious and should be supervised by a clinician with limited duration and monitoring.
For further reading, patients are advised to consult NHS guidance on topical steroids and contact their GP or community pharmacist if unsure.
Guidelines For Proper Use
When counselling a patient, pharmacists should follow a clear stepwise approach to ensure safe application and monitoring.
- Confirm indication and check for contraindications and current systemic steroid use.
- Demonstrate fingertip unit dosing and advise a thin film application only to affected areas.
- Advise maximum continuous duration (commonly 2–4 weeks) and discuss plans to switch to maintenance or steroid‑sparing therapy.
- Warn against occlusive dressings unless specifically instructed by a clinician.
- Document concurrent steroid prescriptions and encourage MHRA Yellow Card reporting for suspected adverse reactions.
Warning Signs That Require Urgent Review:
- Sudden severe skin thinning or new telangiectasia over treated areas.
- Signs of local infection such as increasing pain, purulent discharge or spreading redness.
- Unexplained fatigue, weight loss or features suggestive of adrenal insufficiency in the context of prolonged use.
Pharmacists should signpost patients to NHS 111 or the GP if warning signs occur and consider dermatology referral for persistent disease beyond recommended courses.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | Greater London | 5-7 days |
| Birmingham | West Midlands | 5-7 days |
| Manchester | Greater Manchester | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Leeds | West Yorkshire | 5-7 days |
| Bristol | South West England | 5-7 days |
| Liverpool | Merseyside | 5-7 days |
| Newcastle | Tyne and Wear | 5-7 days |
| Nottingham | Nottinghamshire | 5-9 days |
| Southampton | South East England | 5-9 days |
| Belfast | Northern Ireland | 5-9 days |
| Cardiff | Wales | 5-9 days |
| Coventry | West Midlands | 5-9 days |
| Sheffield | South Yorkshire | 5-9 days |